Treating patients with deep mycoses of the maxillofacial region against a COVID-19 background

Abstract

BACKGROUND: Complications characterized by necrosis of the nasal mucosa and the hard palate, as well as the middle and lower nasal concha with exposure of the alveolar process, destruction of the posterior wall of the maxillary sinus and the bottom of the orbit caused by a fungal infection were noted during the COVID-19 pandemic. By January 2022, such cases had been documented in 18 countries worldwide. The main predisposing factors for this condition are diabetes mellitus and inadequate use of corticosteroids. Rhinocerebral mucormycosis or zygomycosis is a rare disease caused by filamentous fungi affecting the nose, paranasal sinuses, and brain.

AIM: To present the treatment strategy for patients with deep mycoses of the maxillofacial region against a background of transferred COVID-19 in the State Clinical Hospital named after F.I. Inozemtsev DZM.

MATERIAL AND METHODS: Fifteen patients with a cerebral form of mucormycosis of the maxillofacial region arose against a background of a new coronavirus infection associated with SARS-CoV-2.

RESULTS: The study shows the importance of timely initiation of radical surgical treatment for the rhinocerebral form of mucormycosis in the maxillofacial region, which arose against the background of SARS-CoV-2, to prevent the spread of osteomyelitic foci in bone tissue.

CONCLUSION: Early diagnosis of mucormycosis, timely treatment with antipsychotic medications and surgical intervention, control of the level of glycemia, and reasonable use of corticosteroids prevented the development of complications.

Keywords

maxillofacial region / purulent-inflammatory diseases / mucormycosis / necrosis of the maxilla

References

[1] Sen M, Lahane S, Lahane TP, et al. Mucor in a Viral Land: A Tale of Two Pathogens. Indian J Ophthalmol. 2021;69(2):244–252. doi: 10.4103/ijo.IJO_3774_20

[2] Sen M., Lahane S., Lahane T.P., et al. Mucor in a Viral Land: A Tale of Two Pathogens // Indian J Ophthalmol. 2021. Vol. 69, N 2. P. 244–252. doi: 10.4103/ijo.IJO_3774_20

[3] Rudramurthy SM, Hoenigl M, Meis JF, et al.; ECMM and ISHAM. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses. 2021;64(9):1028–1037. doi: 10.1111/myc.13335

[4] Rudramurthy S.M., Hoenigl M., Meis J.F., et al; ECMM and ISHAM. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries // Mycoses. 2021. Vol. 64, N 9. P. 1028–1037. doi: 10.1111/myc.13335

[5] Joshi S, Dubey N, Havaldar R, Wakhlu A. Post-COVID rhinocerebral mucormycosis: an otolaryngologists nightmare. Int J Otorhinolaryngol Head Neck Surg. 2021;7(7):1144–1149. doi: 10.18203/issn.2454-5929.ijohns20212450

[6] Joshi S., Dubey N., Havaldar R., Wakhlu A. Post-COVID rhinocerebral mucormycosis: an otolaryngologists nightmare // Int J Otorhinolaryngol Head Neck Surg. 2021. Vol. 7, N 7. P. 1144–1149. doi: 10.18203/issn.2454-5929.ijohns20212450

[7] Brown SR, Shah IA, Grinstead M. Rhinocerebral mucormycosis caused by Apophysomyces elegans. Am J Rhinol. 1998;12(4):289–292. doi: 10.2500/105065898781389994

[8] Brown S.R., Shah I.A., Grinstead M. Rhinocerebral mucormycosis caused by Apophysomyces elegans // Am J Rhinol. 1998. Vol. 12, N 4. P. 289–292. doi: 10.2500/105065898781389994

[9] Dvoryanchikov VV, Mironov VG, Chernysh AV, et al. The present-day aspects of diagnostics of fungal balls of paranasal sinuses. Rossiiskaya Otorinolaringologiya. 2019;18(3):33–38. (In Russ). doi: 10.18692/1810-4800-2019-3-33-38

[10] Дворянчиков В.В., Миронов В.Г., Черныш А.В., и др. Современные аспекты диагностики грибковых тел околоносовых пазух // Российская оториноларингология. 2019. Т. 18, № 3. С. 33–38. doi: 10.18692/1810-4800-2019-3-33-38

[11] Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi: 10.1093/cid/ciz1008

[12] Donnelly J.P., Chen S.C., Kauffman C.A., et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium // Clin Infect Dis. 2020. Vol. 71, N 6. P. 1367–1376. doi: 10.1093/cid/ciz1008

RIGHTS & PERMISSIONS

Markarov A.E., Naumenko M.V., Orazvaliev A.I., Dubov D.V., Zhabko E.V.